| Biomarker ID | 1869 |
| PMID | 30373654 |
| Year | 2018 |
| Biomarker | Methlyation Status of APC |
| Biomarker Basis | Methylation Based |
| Biomolecule | Methylation |
| Source | Tissue |
| Subjects | Humans |
| Regulation | Methylated in Gleason Grade 2-5 |
| Odds Ratio/Hazard Ratio/Relative Risk | NA |
| Effect on Pathways | Pathways include: Pathways in cancer, Signal transduction, Irinotecan pathway, Actin cytoskeleton regulation, Apoptosis |
| Experiment | Low & Intermediate Risk Vs High Risk |
| Type of Biomarker | Prognostic |
| Cohort | 15 normal prostate tissues along with 74 Prostate cancer samples were selected for analysis. 33 patients had Low & Intermediate Risk and 41 had High RIsk |
| Senstivity | NA |
| Specificity | NA |
| AUC | NA |
| Accuracy | NA |
| Level Of Significance | p<0.01 |
| Method Used | KAPA SYBR FAST qPCR Kit |
| Clinical | No |
| Remarks | Risk was catergorized according to CAPRA Score |
| Clinical Trial Number | NA |
| Degree Of Validity | Validated on independent patient dataset |
| Technical Name | NA |